시장조사보고서

세계의 생물 제제와 바이오시밀러 매출 동향 2018 Global Biologics and Biosimilars Sales Market Report 2018

  • cover image
  • 상품 코드 : 375188
  • 리서치사 : QYResearch
  • 발행일 : 2018년 07월
  • 페이지 정보 : 영문 110 Pages
  • 배송 : 3~5 영업일 이내
  • 가격 :

요약

세계 시장의 생물 제제와 바이오시밀러 매출(소비) 동향을 조사했으며, 특히 주요 미국, 유럽, 중국, 일본, 동남아시아, 인도 기업의 매출, 가격, 수익, 시장 점유율에 관한 정보를 전해드립니다.

1 생물 제제와 바이오시밀러 시장 개요

2 세계 생물 제제와 바이오시밀러 시장의 경쟁 : 시장 진출기업/공급업체·종류·용도별

3 미국의 생물 제제와 바이오시밀러 (수량, 매출액, 판매가격)

4 유럽의 생물 제제와 바이오시밀러 (수량, 매출액, 판매가격)

5 중국의 생물 제제와 바이오시밀러 (수량, 매출액, 판매가격)

6 일본의 생물 제제와 바이오시밀러 (수량, 매출액, 판매가격)

7 동남아시아의 생물 제제와 바이오시밀러 (수량, 매출, 판매가격)

8 인도의 생물 제제와 바이오시밀러 (수량, 매출, 판매가격)

9 세계의 생물 제제와 바이오시밀러 시장 진출기업/공급업체 프로파일 및 매출 데이터

  • 9.1 Pfizer
  • 9.2 Roche
  • 9.3 Amgen
  • 9.4 AbbVie
  • 9.5 Sanofi
  • 9.6 Johnson & Johnson
  • 9.7 Novo Nordisk
  • 9.8 Novartis
  • 9.9 Merck
  • 9.10 Lilly
  • 9.11 3sbio
  • 9.12 Changchun High Tech
  • 9.13 CP Guojian Pharmacy
  • 9.14 Biotech Pharma
  • 9.15 Gelgen Biopharma
  • 9.16 Sandoz
  • 9.17 Teva
  • 9.18 Hospira
  • 9.19 Mylan

10 생물 제제와 바이오시밀러 제조비용 분석

11 산업체인, 구매 전략, 다운스트림(Downstream) 구매자

12 마케팅 전략 분석 : 유통업체, 무역업체

13 시장 영향요인 분석

14 생물 제제와 바이오시밀러 세계 시장 예측 (2018-2025)

15 조사 결과와 결론

16 부록


목차

This report studies the global Biologics and Biosimilars market status and forecast, categorizes the global Biologics and Biosimilars market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Biologics and Biosimilars market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major players covered in this report

  • Pfizer
  • Roche
  • Amgen
  • AbbVie
  • Sanofi
  • Johnson & Johnson
  • Novo Nordisk
  • Novartis
  • Merck
  • Lilly
  • 3sbio
  • Changchun High Tech
  • CP Guojian Pharmacy
  • Biotech Pharma
  • Gelgen Biopharma
  • Sandoz
  • Teva
  • Hospira
  • Mylan

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

We can also provide the customized separate regional or country-level reports, for the following regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Singapore
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Central & South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

  • Antibiotic
  • Enzyme
  • Hormone
  • Non-Patented Biological Reagents
  • Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Other

The study objectives of this report are:

  • To analyze and study the global Biologics and Biosimilars sales, value, status (2013-2017) and forecast (2018-2025);
  • To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
  • Focuses on the key Biologics and Biosimilars players, to study the sales, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biologics and Biosimilars are as follows:

  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Biologics and Biosimilars Manufacturers

Biologics and Biosimilars Distributors/Traders/Wholesalers

Biologics and Biosimilars Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Biologics and Biosimilars market, by end-use.

Detailed analysis and profiles of additional market players.

Table of Contents

1 Biologics and Biosimilars Market Overview

  • 1.1 Product Overview and Scope of Biologics and Biosimilars
  • 1.2 Classification of Biologics and Biosimilars by Product Category
    • 1.2.1 Global Biologics and Biosimilars Market Size (Sales) Comparison by Type (2013-2025)
    • 1.2.2 Global Biologics and Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2017
    • 1.2.3 Antibiotic
    • 1.2.4 Enzyme
    • 1.2.5 Hormone
    • 1.2.6 Non-Patented Biological Reagents
    • 1.2.7 Other
  • 1.3 Global Biologics and Biosimilars Market by Application/End Users
    • 1.3.1 Global Biologics and Biosimilars Sales (Volume) and Market Share Comparison by Application (2013-2025)
    • 1.3.1 Tumor
    • 1.3.2 Diabetes
    • 1.3.3 Cardiovascular
    • 1.3.4 Hemophilia
    • 1.3.5 Other
  • 1.4 Global Biologics and Biosimilars Market by Region
    • 1.4.1 Global Biologics and Biosimilars Market Size (Value) Comparison by Region (2013-2025)
    • 1.4.2 United States Biologics and Biosimilars Status and Prospect (2013-2025)
    • 1.4.3 Europe Biologics and Biosimilars Status and Prospect (2013-2025)
    • 1.4.4 China Biologics and Biosimilars Status and Prospect (2013-2025)
    • 1.4.5 Japan Biologics and Biosimilars Status and Prospect (2013-2025)
    • 1.4.6 Southeast Asia Biologics and Biosimilars Status and Prospect (2013-2025)
    • 1.4.7 India Biologics and Biosimilars Status and Prospect (2013-2025)
  • 1.5 Global Market Size (Value and Volume) of Biologics and Biosimilars (2013-2025)
    • 1.5.1 Global Biologics and Biosimilars Sales and Growth Rate (2013-2025)
    • 1.5.2 Global Biologics and Biosimilars Revenue and Growth Rate (2013-2025)

2 Global Biologics and Biosimilars Competition by Players/Suppliers, Type and Application

  • 2.1 Global Biologics and Biosimilars Market Competition by Players/Suppliers
    • 2.1.1 Global Biologics and Biosimilars Sales and Market Share of Key Players/Suppliers (2013-2018)
    • 2.1.2 Global Biologics and Biosimilars Revenue and Share by Players/Suppliers (2013-2018)
  • 2.2 Global Biologics and Biosimilars (Volume and Value) by Type
    • 2.2.1 Global Biologics and Biosimilars Sales and Market Share by Type (2013-2018)
    • 2.2.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2013-2018)
  • 2.3 Global Biologics and Biosimilars (Volume and Value) by Region
    • 2.3.1 Global Biologics and Biosimilars Sales and Market Share by Region (2013-2018)
    • 2.3.2 Global Biologics and Biosimilars Revenue and Market Share by Region (2013-2018)
  • 2.4 Global Biologics and Biosimilars (Volume) by Application

3 United States Biologics and Biosimilars (Volume, Value and Sales Price)

  • 3.1 United States Biologics and Biosimilars Sales and Value (2013-2018)
    • 3.1.1 United States Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    • 3.1.2 United States Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
    • 3.1.3 United States Biologics and Biosimilars Sales Price Trend (2013-2018)
  • 3.2 United States Biologics and Biosimilars Sales Volume and Market Share by Players (2013-2018)
  • 3.3 United States Biologics and Biosimilars Sales Volume and Market Share by Type (2013-2018)
  • 3.4 United States Biologics and Biosimilars Sales Volume and Market Share by Application (2013-2018)

4 Europe Biologics and Biosimilars (Volume, Value and Sales Price)

  • 4.1 Europe Biologics and Biosimilars Sales and Value (2013-2018)
    • 4.1.1 Europe Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    • 4.1.2 Europe Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
    • 4.1.3 Europe Biologics and Biosimilars Sales Price Trend (2013-2018)
  • 4.2 Europe Biologics and Biosimilars Sales Volume and Market Share by Players (2013-2018)
  • 4.3 Europe Biologics and Biosimilars Sales Volume and Market Share by Type (2013-2018)
  • 4.4 Europe Biologics and Biosimilars Sales Volume and Market Share by Application (2013-2018)

5 China Biologics and Biosimilars (Volume, Value and Sales Price)

  • 5.1 China Biologics and Biosimilars Sales and Value (2013-2018)
    • 5.1.1 China Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    • 5.1.2 China Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
    • 5.1.3 China Biologics and Biosimilars Sales Price Trend (2013-2018)
  • 5.2 China Biologics and Biosimilars Sales Volume and Market Share by Players (2013-2018)
  • 5.3 China Biologics and Biosimilars Sales Volume and Market Share by Type (2013-2018)
  • 5.4 China Biologics and Biosimilars Sales Volume and Market Share by Application (2013-2018)

6 Japan Biologics and Biosimilars (Volume, Value and Sales Price)

  • 6.1 Japan Biologics and Biosimilars Sales and Value (2013-2018)
    • 6.1.1 Japan Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    • 6.1.2 Japan Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
    • 6.1.3 Japan Biologics and Biosimilars Sales Price Trend (2013-2018)
  • 6.2 Japan Biologics and Biosimilars Sales Volume and Market Share by Players (2013-2018)
  • 6.3 Japan Biologics and Biosimilars Sales Volume and Market Share by Type (2013-2018)
  • 6.4 Japan Biologics and Biosimilars Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Biologics and Biosimilars (Volume, Value and Sales Price)

  • 7.1 Southeast Asia Biologics and Biosimilars Sales and Value (2013-2018)
    • 7.1.1 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    • 7.1.2 Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
    • 7.1.3 Southeast Asia Biologics and Biosimilars Sales Price Trend (2013-2018)
  • 7.2 Southeast Asia Biologics and Biosimilars Sales Volume and Market Share by Players (2013-2018)
  • 7.3 Southeast Asia Biologics and Biosimilars Sales Volume and Market Share by Type (2013-2018)
  • 7.4 Southeast Asia Biologics and Biosimilars Sales Volume and Market Share by Application (2013-2018)

8 India Biologics and Biosimilars (Volume, Value and Sales Price)

  • 8.1 India Biologics and Biosimilars Sales and Value (2013-2018)
    • 8.1.1 India Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    • 8.1.2 India Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
    • 8.1.3 India Biologics and Biosimilars Sales Price Trend (2013-2018)
  • 8.2 India Biologics and Biosimilars Sales Volume and Market Share by Players (2013-2018)
  • 8.3 India Biologics and Biosimilars Sales Volume and Market Share by Type (2013-2018)
  • 8.4 India Biologics and Biosimilars Sales Volume and Market Share by Application (2013-2018)

9 Global Biologics and Biosimilars Players/Suppliers Profiles and Sales Data

  • 9.1 Pfizer
    • 9.1.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.1.2 Biologics and Biosimilars Product Category, Application and Specification
      • 9.1.2.1 Product A
      • 9.1.2.2 Product B
    • 9.1.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.1.4 Main Business/Business Overview
  • 9.2 Roche
    • 9.2.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.2.2 Biologics and Biosimilars Product Category, Application and Specification
      • 9.2.2.1 Product A
      • 9.2.2.2 Product B
    • 9.2.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.2.4 Main Business/Business Overview
  • 9.3 Amgen
    • 9.3.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.3.2 Biologics and Biosimilars Product Category, Application and Specification
      • 9.3.2.1 Product A
      • 9.3.2.2 Product B
    • 9.3.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.3.4 Main Business/Business Overview
  • 9.4 AbbVie
    • 9.4.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.4.2 Biologics and Biosimilars Product Category, Application and Specification
      • 9.4.2.1 Product A
      • 9.4.2.2 Product B
    • 9.4.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.4.4 Main Business/Business Overview
  • 9.5 Sanofi
    • 9.5.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.5.2 Biologics and Biosimilars Product Category, Application and Specification
      • 9.5.2.1 Product A
      • 9.5.2.2 Product B
    • 9.5.3 Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.5.4 Main Business/Business Overview
  • 9.6 Johnson & Johnson
    • 9.6.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.6.2 Biologics and Biosimilars Product Category, Application and Specification
      • 9.6.2.1 Product A
      • 9.6.2.2 Product B
    • 9.6.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.6.4 Main Business/Business Overview
  • 9.7 Novo Nordisk
    • 9.7.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.7.2 Biologics and Biosimilars Product Category, Application and Specification
      • 9.7.2.1 Product A
      • 9.7.2.2 Product B
    • 9.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.7.4 Main Business/Business Overview
  • 9.8 Novartis
    • 9.8.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.8.2 Biologics and Biosimilars Product Category, Application and Specification
      • 9.8.2.1 Product A
      • 9.8.2.2 Product B
    • 9.8.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.8.4 Main Business/Business Overview
  • 9.9 Merck
    • 9.9.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.9.2 Biologics and Biosimilars Product Category, Application and Specification
      • 9.9.2.1 Product A
      • 9.9.2.2 Product B
    • 9.9.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.9.4 Main Business/Business Overview
  • 9.10 Lilly
    • 9.10.1 Company Basic Information, Manufacturing Base and Competitors
    • 9.10.2 Biologics and Biosimilars Product Category, Application and Specification
      • 9.10.2.1 Product A
      • 9.10.2.2 Product B
    • 9.10.3 Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
    • 9.10.4 Main Business/Business Overview
  • 9.11 3sbio
  • 9.12 Changchun High Tech
  • 9.13 CP Guojian Pharmacy
  • 9.14 Biotech Pharma
  • 9.15 Gelgen Biopharma
  • 9.16 Sandoz
  • 9.17 Teva
  • 9.18 Hospira
  • 9.19 Mylan

10 Biologics and Biosimilars Maufacturing Cost Analysis

  • 10.1 Biologics and Biosimilars Key Raw Materials Analysis
    • 10.1.1 Key Raw Materials
    • 10.1.2 Price Trend of Key Raw Materials
    • 10.1.3 Key Suppliers of Raw Materials
    • 10.1.4 Market Concentration Rate of Raw Materials
  • 10.2 Proportion of Manufacturing Cost Structure
    • 10.2.1 Raw Materials
    • 10.2.2 Labor Cost
    • 10.2.3 Manufacturing Process Analysis of Biologics and Biosimilars
  • 10.3 Manufacturing Process Analysis of Biologics and Biosimilars

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

  • 11.1 Biologics and Biosimilars Industrial Chain Analysis
  • 11.2 Upstream Raw Materials Sourcing
  • 11.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2017
  • 11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

  • 12.1 Marketing Channel
    • 12.1.1 Direct Marketing
    • 12.1.2 Indirect Marketing
    • 12.1.3 Marketing Channel Development Trend
  • 12.2 Market Positioning
    • 12.2.1 Pricing Strategy
    • 12.2.2 Brand Strategy
    • 12.2.3 Target Client
  • 12.3 Distributors/Traders List

13 Market Effect Factors Analysis

  • 13.1 Technology Progress/Risk
    • 13.1.1 Substitutes Threat
    • 13.1.2 Technology Progress in Related Industry
  • 13.2 Consumer Needs/Customer Preference Change
  • 13.3 Economic/Political Environmental Change

14 Global Biologics and Biosimilars Market Forecast (2018-2025)

  • 14.1 Global Biologics and Biosimilars Sales Volume, Revenue and Price Forecast (2018-2025)
    • 14.1.1 Global Biologics and Biosimilars Sales Volume and Growth Rate Forecast (2018-2025)
    • 14.1.2 Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2018-2025)
    • 14.1.3 Global Biologics and Biosimilars Price and Trend Forecast (2018-2025)
  • 14.2 Global Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
    • 14.2.1 Global Biologics and Biosimilars Sales Volume and Growth Rate Forecast by Regions (2018-2025)
    • 14.2.2 Global Biologics and Biosimilars Revenue and Growth Rate Forecast by Regions (2018-2025)
    • 14.2.3 United States Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    • 14.2.4 Europe Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    • 14.2.5 China Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    • 14.2.6 Japan Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    • 14.2.7 Southeast Asia Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    • 14.2.8 India Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  • 14.3 Global Biologics and Biosimilars Sales Volume, Revenue and Price Forecast by Type (2018-2025)
    • 14.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2018-2025)
    • 14.3.2 Global Biologics and Biosimilars Revenue Forecast by Type (2018-2025)
    • 14.3.3 Global Biologics and Biosimilars Price Forecast by Type (2018-2025)
  • 14.4 Global Biologics and Biosimilars Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix

  • 16.1 Methodology/Research Approach
    • 16.1.1 Research Programs/Design
    • 16.1.2 Market Size Estimation
    • 16.1.3 Market Breakdown and Data Triangulation
  • 16.2 Data Source
    • 16.2.1 Secondary Sources
    • 16.2.2 Primary Sources
  • 16.3 Disclaimer

List of Tables and Figures

  • Figure Product Picture of Biologics and Biosimilars
  • Figure Global Biologics and Biosimilars Sales Volume Comparison (K Units) by Type (2013-2025)
  • Figure Global Biologics and Biosimilars Sales Volume Market Share by Type (Product Category) in 2017
  • Figure Antibiotic Product Picture
  • Figure Enzyme Product Picture
  • Figure Hormone Product Picture
  • Figure Non-Patented Biological Reagents Product Picture
  • Figure Other Product Picture
  • Figure Global Biologics and Biosimilars Sales Comparison (K Units) by Application (2013-2025)
  • Figure Global Sales Market Share of Biologics and Biosimilars by Application in 2017
  • Figure Tumor Examples
  • Table Key Downstream Customer in Tumor
  • Figure Diabetes Examples
  • Table Key Downstream Customer in Diabetes
  • Figure Cardiovascular Examples
  • Table Key Downstream Customer in Cardiovascular
  • Figure Hemophilia Examples
  • Table Key Downstream Customer in Hemophilia
  • Figure Other Examples
  • Table Key Downstream Customer in Other
  • Figure Global Biologics and Biosimilars Market Size (Million USD) by Regions (2013-2025)
  • Figure United States Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Global Biologics and Biosimilars Sales Volume (K Units) and Growth Rate (2013-2025)
  • Figure Global Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Global Market Major Players Biologics and Biosimilars Sales Volume (K Units) (2013-2018)
  • Table Global Biologics and Biosimilars Sales (K Units) of Key Players/Suppliers (2013-2018)
  • Table Global Biologics and Biosimilars Sales Share by Players/Suppliers (2013-2018)
  • Figure 2017 Biologics and Biosimilars Sales Share by Players/Suppliers
  • Figure 2017 Biologics and Biosimilars Sales Share by Players/Suppliers
  • Figure Global Biologics and Biosimilars Revenue (Million USD) by Players/Suppliers (2013-2018)
  • Table Global Biologics and Biosimilars Revenue (Million USD) by Players/Suppliers (2013-2018)
  • Table Global Biologics and Biosimilars Revenue Share by Players/Suppliers (2013-2018)
  • Table 2017 Global Biologics and Biosimilars Revenue Share by Players
  • Table 2017 Global Biologics and Biosimilars Revenue Share by Players
  • Table Global Biologics and Biosimilars Sales (K Units) and Market Share by Type (2013-2018)
  • Table Global Biologics and Biosimilars Sales Share (K Units) by Type (2013-2018)
  • Figure Sales Market Share of Biologics and Biosimilars by Type (2013-2018)
  • Figure Global Biologics and Biosimilars Sales Growth Rate by Type (2013-2018)
  • Table Global Biologics and Biosimilars Revenue (Million USD) and Market Share by Type (2013-2018)
  • Table Global Biologics and Biosimilars Revenue Share by Type (2013-2018)
  • Figure Revenue Market Share of Biologics and Biosimilars by Type (2013-2018)
  • Figure Global Biologics and Biosimilars Revenue Growth Rate by Type (2013-2018)
  • Table Global Biologics and Biosimilars Sales Volume (K Units) and Market Share by Region (2013-2018)
  • Table Global Biologics and Biosimilars Sales Share by Region (2013-2018)
  • Figure Sales Market Share of Biologics and Biosimilars by Region (2013-2018)
  • Figure Global Biologics and Biosimilars Sales Growth Rate by Region in 2017
  • Table Global Biologics and Biosimilars Revenue (Million USD) and Market Share by Region (2013-2018)
  • Table Global Biologics and Biosimilars Revenue Share (%) by Region (2013-2018)
  • Figure Revenue Market Share of Biologics and Biosimilars by Region (2013-2018)
  • Figure Global Biologics and Biosimilars Revenue Growth Rate by Region in 2017
  • Table Global Biologics and Biosimilars Revenue (Million USD) and Market Share by Region (2013-2018)
  • Table Global Biologics and Biosimilars Revenue Share (%) by Region (2013-2018)
  • Figure Revenue Market Share of Biologics and Biosimilars by Region (2013-2018)
  • Figure Global Biologics and Biosimilars Revenue Market Share by Region in 2017
  • Table Global Biologics and Biosimilars Sales Volume (K Units) and Market Share by Application (2013-2018)
  • Table Global Biologics and Biosimilars Sales Share (%) by Application (2013-2018)
  • Figure Sales Market Share of Biologics and Biosimilars by Application (2013-2018)
  • Figure Global Biologics and Biosimilars Sales Market Share by Application (2013-2018)
  • Figure United States Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
  • Figure United States Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
  • Figure United States Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
  • Table United States Biologics and Biosimilars Sales Volume (K Units) by Players (2013-2018)
  • Table United States Biologics and Biosimilars Sales Volume Market Share by Players (2013-2018)
  • Figure United States Biologics and Biosimilars Sales Volume Market Share by Players in 2017
  • Table United States Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
  • Table United States Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
  • Figure United States Biologics and Biosimilars Sales Volume Market Share by Type in 2017
  • Table United States Biologics and Biosimilars Sales Volume (K Units) by Application (2013-2018)
  • Table United States Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
  • Figure United States Biologics and Biosimilars Sales Volume Market Share by Application in 2017
  • Figure Europe Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
  • Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
  • Figure Europe Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
  • Table Europe Biologics and Biosimilars Sales Volume (K Units) by Players (2013-2018)
  • Table Europe Biologics and Biosimilars Sales Volume Market Share by Players (2013-2018)
  • Figure Europe Biologics and Biosimilars Sales Volume Market Share by Players in 2017
  • Table Europe Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
  • Table Europe Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
  • Figure Europe Biologics and Biosimilars Sales Volume Market Share by Type in 2017
  • Table Europe Biologics and Biosimilars Sales Volume (K Units) by Application (2013-2018)
  • Table Europe Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
  • Figure Europe Biologics and Biosimilars Sales Volume Market Share by Application in 2017
  • Figure China Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
  • Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
  • Figure China Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
  • Table China Biologics and Biosimilars Sales Volume (K Units) by Players (2013-2018)
  • Table China Biologics and Biosimilars Sales Volume Market Share by Players (2013-2018)
  • Figure China Biologics and Biosimilars Sales Volume Market Share by Players in 2017
  • Table China Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
  • Table China Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
  • Figure China Biologics and Biosimilars Sales Volume Market Share by Type in 2017
  • Table China Biologics and Biosimilars Sales Volume (K Units) by Application (2013-2018)
  • Table China Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
  • Figure China Biologics and Biosimilars Sales Volume Market Share by Application in 2017
  • Figure Japan Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
  • Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
  • Figure Japan Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
  • Table Japan Biologics and Biosimilars Sales Volume (K Units) by Players (2013-2018)
  • Table Japan Biologics and Biosimilars Sales Volume Market Share by Players (2013-2018)
  • Figure Japan Biologics and Biosimilars Sales Volume Market Share by Players in 2017
  • Table Japan Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
  • Table Japan Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
  • Figure Japan Biologics and Biosimilars Sales Volume Market Share by Type in 2017
  • Table Japan Biologics and Biosimilars Sales Volume (K Units) by Application (2013-2018)
  • Table Japan Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
  • Figure Japan Biologics and Biosimilars Sales Volume Market Share by Application in 2017
  • Figure Southeast Asia Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
  • Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
  • Figure Southeast Asia Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
  • Table Southeast Asia Biologics and Biosimilars Sales Volume (K Units) by Players (2013-2018)
  • Table Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Players (2013-2018)
  • Figure Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Players in 2017
  • Table Southeast Asia Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
  • Table Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
  • Figure Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Type in 2017
  • Table Southeast Asia Biologics and Biosimilars Sales Volume (K Units) by Application (2013-2018)
  • Table Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
  • Figure Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Application in 2017
  • Figure India Biologics and Biosimilars Sales (K Units) and Growth Rate (2013-2018)
  • Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
  • Figure India Biologics and Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
  • Table India Biologics and Biosimilars Sales Volume (K Units) by Players (2013-2018)
  • Table India Biologics and Biosimilars Sales Volume Market Share by Players (2013-2018)
  • Figure India Biologics and Biosimilars Sales Volume Market Share by Players in 2017
  • Table India Biologics and Biosimilars Sales Volume (K Units) by Type (2013-2018)
  • Table India Biologics and Biosimilars Sales Volume Market Share by Type (2013-2018)
  • Figure India Biologics and Biosimilars Sales Volume Market Share by Type in 2017
  • Table India Biologics and Biosimilars Sales Volume (K Units) by Application (2013-2018)
  • Table India Biologics and Biosimilars Sales Volume Market Share by Application (2013-2018)
  • Figure India Biologics and Biosimilars Sales Volume Market Share by Application in 2017
  • Table Pfizer Basic Information List
  • Table Pfizer Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Pfizer Biologics and Biosimilars Sales Growth Rate (2013-2018)
  • Figure Pfizer Biologics and Biosimilars Sales Global Market Share (2013-2018)
  • Figure Pfizer Biologics and Biosimilars Revenue Global Market Share (2013-2018)
  • Table Roche Basic Information List
  • Table Roche Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Roche Biologics and Biosimilars Sales Growth Rate (2013-2018)
  • Figure Roche Biologics and Biosimilars Sales Global Market Share (2013-2018)
  • Figure Roche Biologics and Biosimilars Revenue Global Market Share (2013-2018)
  • Table Amgen Basic Information List
  • Table Amgen Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Amgen Biologics and Biosimilars Sales Growth Rate (2013-2018)
  • Figure Amgen Biologics and Biosimilars Sales Global Market Share (2013-2018
  • Figure Amgen Biologics and Biosimilars Revenue Global Market Share (2013-2018)
  • Table AbbVie Basic Information List
  • Table AbbVie Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure AbbVie Biologics and Biosimilars Sales Growth Rate (2013-2018)
  • Figure AbbVie Biologics and Biosimilars Sales Global Market Share (2013-2018)
  • Figure AbbVie Biologics and Biosimilars Revenue Global Market Share (2013-2018)
  • Table Sanofi Basic Information List
  • Table Sanofi Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Sanofi Biologics and Biosimilars Sales Growth Rate (2013-2018)
  • Figure Sanofi Biologics and Biosimilars Sales Global Market Share (2013-2018)
  • Figure Sanofi Biologics and Biosimilars Revenue Global Market Share (2013-2018)
  • Table Johnson & Johnson Basic Information List
  • Table Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Johnson & Johnson Biologics and Biosimilars Sales Growth Rate (2013-2018)
  • Figure Johnson & Johnson Biologics and Biosimilars Sales Global Market Share (2013-2018
  • Figure Johnson & Johnson Biologics and Biosimilars Revenue Global Market Share (2013-2018)
  • Table Novo Nordisk Basic Information List
  • Table Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Novo Nordisk Biologics and Biosimilars Sales Growth Rate (2013-2018)
  • Figure Novo Nordisk Biologics and Biosimilars Sales Global Market Share (2013-2018)
  • Figure Novo Nordisk Biologics and Biosimilars Revenue Global Market Share (2013-2018)
  • Table Novartis Basic Information List
  • Table Novartis Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Novartis Biologics and Biosimilars Sales Growth Rate (2013-2018)
  • Figure Novartis Biologics and Biosimilars Sales Global Market Share (2013-2018
  • Figure Novartis Biologics and Biosimilars Revenue Global Market Share (2013-2018)
  • Table Merck Basic Information List
  • Table Merck Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Merck Biologics and Biosimilars Sales Growth Rate (2013-2018)
  • Figure Merck Biologics and Biosimilars Sales Global Market Share (2013-2018)
  • Figure Merck Biologics and Biosimilars Revenue Global Market Share (2013-2018)
  • Table Lilly Basic Information List
  • Table Lilly Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Lilly Biologics and Biosimilars Sales Growth Rate (2013-2018)
  • Figure Lilly Biologics and Biosimilars Sales Global Market Share (2013-2018)
  • Figure Lilly Biologics and Biosimilars Revenue Global Market Share (2013-2018)
  • Table 3sbio Basic Information List
  • Table Changchun High Tech Basic Information List
  • Table CP Guojian Pharmacy Basic Information List
  • Table Biotech Pharma Basic Information List
  • Table Gelgen Biopharma Basic Information List
  • Table Sandoz Basic Information List
  • Table Teva Basic Information List
  • Table Hospira Basic Information List
  • Table Mylan Basic Information List
  • Table Production Base and Market Concentration Rate of Raw Material
  • Figure Price Trend of Key Raw Materials
  • Table Key Suppliers of Raw Materials
  • Figure Manufacturing Cost Structure of Biologics and Biosimilars
  • Figure Manufacturing Process Analysis of Biologics and Biosimilars
  • Figure Biologics and Biosimilars Industrial Chain Analysis
  • Table Raw Materials Sources of Biologics and Biosimilars Major Players in 2017
  • Table Major Buyers of Biologics and Biosimilars
  • Table Distributors/Traders List
  • Figure Global Biologics and Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
  • Figure Global Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Figure Global Biologics and Biosimilars Price (USD/Unit) and Trend Forecast (2018-2025)
  • Table Global Biologics and Biosimilars Sales Volume (K Units) Forecast by Regions (2018-2025)
  • Figure Global Biologics and Biosimilars Sales Volume Market Share Forecast by Regions (2018-2025)
  • Figure Global Biologics and Biosimilars Sales Volume Market Share Forecast by Regions in 2025
  • Table Global Biologics and Biosimilars Revenue (Million USD) Forecast by Regions (2018-2025)
  • Figure Global Biologics and Biosimilars Revenue Market Share Forecast by Regions (2018-2025)
  • Figure Global Biologics and Biosimilars Revenue Market Share Forecast by Regions in 2025
  • Figure United States Biologics and Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
  • Figure United States Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Figure Europe Biologics and Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
  • Figure Europe Biologics and Biosimilars Revenue and Growth Rate Forecast (2018-2025)
  • Figure China Biologics and Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
  • Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Figure Japan Biologics and Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
  • Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Figure Southeast Asia Biologics and Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
  • Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Figure India Biologics and Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
  • Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table Global Biologics and Biosimilars Sales (K Units) Forecast by Type (2018-2025)
  • Figure Global Biologics and Biosimilars Sales Volume Market Share Forecast by Type (2018-2025)
  • Table Global Biologics and Biosimilars Revenue (Million USD) Forecast by Type (2018-2025)
  • Figure Global Biologics and Biosimilars Revenue Market Share Forecast by Type (2018-2025)
  • Table Global Biologics and Biosimilars Price (USD/Unit) Forecast by Type (2018-2025)
  • Table Global Biologics and Biosimilars Sales (K Units) Forecast by Application (2018-2025)
  • Figure Global Biologics and Biosimilars Sales Market Share Forecast by Application (2018-2025)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources

생물 제제와 바이오시밀러 관련자료

TOP
회사소개 이용약관 개인정보 처리방침 사이트맵

© Copyright 2011-2018, Global Information, Inc. All rights reserved.